Cardiex Ltd
ASX:CDX
Cardiex Ltd
ASX:CDX
Price:
0.054 AUD
1.89%
Market Closed
Updated:
May 5, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
0.8
Current
13.1
Median
2.5
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=0.8
Enterprise Value
/
10.2m
Revenue
12.9m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| AU |
|
Cardiex Ltd
ASX:CDX
|
10.5m AUD | 0.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 17.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 6.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 4.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 3.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.2 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.1 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
N/A
2-Years Forward
EV/S
0.6
3-Years Forward
EV/S
0.2
You don't have any saved screeners yet
